In this pilot study, we compared the difference in detection rates of PCa between PSMA-TB and TRUS-GB and developed a novel transgluteal PSMA-TB technique, which was easy to perform in the prone position. The gene discussed is FOLH1; the disease is posterior cortical atrophy.